rdf:type |
|
lifeskim:mentions |
umls-concept:C0040578,
umls-concept:C0183517,
umls-concept:C0332293,
umls-concept:C0439234,
umls-concept:C0677874,
umls-concept:C0854761,
umls-concept:C0868930,
umls-concept:C1269955,
umls-concept:C1314677,
umls-concept:C1413096,
umls-concept:C1524072,
umls-concept:C1533148,
umls-concept:C2699153
|
pubmed:issue |
12
|
pubmed:dateCreated |
2011-1-12
|
pubmed:abstractText |
Frequently advanced or recurrent esophageal cancer was invasive trachea and often causing hemoptysis, stenosis and dyspnea. Occasionally, these cases were treated by a placement of tracheal stent. The placement effect was quickly and a main symptom of dyspnea was improved dramatically. However, the most of the cases were in poor prognosis with advanced cancer treated by chemo-radiotherapy (CRT). We experienced a case of recurrent esophageal cancer with tracheal invasion treated by placement of tracheal expandable metallic stent (EMS). A case was a 73-year-old man (at first admission). He was performed esophagectomy with tracheotomy against esophageal carcinoma at cervical portion. Eighteen month later, a local recurrence with tracheal invasion was appeared. The tracheal covered stent was inserted at the recurrent site. After stenting, CRT was performed with 5-FU and docetaxel. The effect of CRT was complete response (CR). Hence, a stent was removed from trachea. No recurrence was observed at the site and maintained a CR condition for two years after CRT.
|
pubmed:language |
jpn
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0385-0684
|
pubmed:author |
pubmed-author:AmagasaHidetoshiH,
pubmed-author:AmiKatsunoriK,
pubmed-author:AndoMasayukiM,
pubmed-author:AraiKuniyoshiK,
pubmed-author:FukudaAkiraA,
pubmed-author:GannoHideakiH,
pubmed-author:HatajiKenichirouK,
pubmed-author:KawasakiYoshihitoY,
pubmed-author:KurokawaToshiakiT,
pubmed-author:NagahamaTakeshiT,
pubmed-author:TeiShikofumiS,
pubmed-author:WatayouYoshihisaY
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2331-3
|
pubmed:meshHeading |
pubmed-meshheading:21224563-Aged,
pubmed-meshheading:21224563-Antimetabolites, Antineoplastic,
pubmed-meshheading:21224563-Antineoplastic Agents,
pubmed-meshheading:21224563-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21224563-Combined Modality Therapy,
pubmed-meshheading:21224563-Esophageal Neoplasms,
pubmed-meshheading:21224563-Fluorouracil,
pubmed-meshheading:21224563-Humans,
pubmed-meshheading:21224563-Male,
pubmed-meshheading:21224563-Neoplasm Invasiveness,
pubmed-meshheading:21224563-Neoplasm Recurrence, Local,
pubmed-meshheading:21224563-Remission Induction,
pubmed-meshheading:21224563-Stents,
pubmed-meshheading:21224563-Taxoids,
pubmed-meshheading:21224563-Trachea,
pubmed-meshheading:21224563-Tracheal Neoplasms,
pubmed-meshheading:21224563-Tracheal Stenosis
|
pubmed:year |
2010
|
pubmed:articleTitle |
[A case of recurrent esophageal cancer with tracheal invasion treated by chemo-radiotherapy (CRT) after placement of tracheal stent that maintained complete response (CR) for two years].
|
pubmed:affiliation |
Dept. of Surgery, Tokyo Metropolitan Toshima Hospital.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|